Medical Dosimetry
Volume 35, Issue 3 , Pages 163-168 , Autumn 2010

Internal Mammary Lymph Node Irradiation Contributes to Heart Dose in Breast Cancer

Presented in part at the annual meeting of the European Society for Therapeutic Radiology and Oncology, Götenborg, Sweden, September 14–17th, 2008.

  • Cyrus Chargari, M.D.

      Affiliations

    • Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    • Department of Radiotherapy and Medical Oncology, Hôpital d'Instruction des Armées du Val-de-Grâce, Paris, France
  • ,
  • Pierre Castadot, M.D., Ph.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Dhara MacDermed, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL
  • ,
  • Christophe Vandekerkhove, Ph.D.

      Affiliations

    • Department of Medical Physics, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Nicolas Bourgois, M.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Paul Van Houtte, M.D.

      Affiliations

    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
  • ,
  • Nicolas Magné, M.D., Ph.D.

      Affiliations

    • Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    • Department of Radio-Oncology, Institut Jules Bordet, Brussels, Belgium
    • Corresponding Author InformationReprint requests to: Nicolas Magné, M.D., Ph.D., Institut Gustave-Roussy, Department of Radiotherapy, 39, rue Camille Desmoulins, 94805 Villejuif cedex, France

Received 31 December 2008 ,Accepted 5 May 2009.

References 

  1. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 1994;12:447–453
  2. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet. 2000;355:1757–1770
  3. Doyle JJ, Neugut AI, Jacobson JS, et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:82–93
  4. Muren LP, Maurstad G, Hafslund R, et al. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother. Oncol. 2000;62:173–183
  5. Hurkmans CW, Borger JH, Bos LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother. Oncol. 2000;55:145–151
  6. Senkus-Konefka E, Jassem J. Cardiovascular effects of breast cancer radiotherapy. Cancer. Treat. Rev. 2007;33:578–593
  7. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet. Oncol. 2005;6:557–565
  8. Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J. Natl. Cancer. Inst. 2005;97:419–424
  9. Farrús B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int. J. Radiat. Oncol. Biol. Phys. 2004;60:715–721
  10. Freedman GM, Fowble BL, Nicolau N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:805–814
  11. Poortmans P. Evidence based radiation oncology: Breast cancer. Radiother. Oncol. 2007;84:84–101
  12. Romestaing P, Ecochard R, Hennequin C, et al. The role of internal mammary irradiation on survival after mastectomy for breast cancer (Results of a phase III SFRO trial). Radiother. Oncol. 2000;56:[abstract 306]
  13. Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s–1990s. Int. J. Radiat. Oncol. Biol. Phys. 2007;69:1484–1495
  14. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:755–762
  15. Hooning MJ, Aleman BM, van Rosmalen AJM, et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:1081–1091
  16. Rutqvist LE, Liedberg A, Hammar N, et al. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1998;40:359–363
  17. Gagliardi G, Lax I, Söderström S, et al. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother. Oncol. 1998;46:63–71
  18. Gyenes G, Rutqvist LE, Liedberg A, et al. Long-term cardiac mortality in a randomized trial of pre- and post-operation radiation therapy versus surgery alone in primary breast cancer. Radiother. Oncol. 1998;48:185–190
  19. Højris I, Overgaard M, Christensen JJ, et al. Morbidity and mortality of ischemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomized trials. Lancet. 1999;354:1425–1430
  20. Rutqvist LE, Johansson H. Mortality by laterality of the primary tumor among 55,000 breast cancer patients from the Swedish Cancer Registry. Br. J. Cancer. 1990;61:866–868
  21. Roychoudhuri R, Robinson D, Putcha V, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC. Cancer. 2007;15:7–9
  22. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  23. Pena PC, Kirova YM, Campana F, et al. Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: Individual variability, questions and answers. Br. J. Radiol. 2009;in press
  24. Kirova YM, Servois V, Campana F, et al. CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Radiother. Oncol. 2006;79:310–315
  25. McGale P, Darby SC. Low doses of ionizing radiation and circulatory disease: A systemic review of the published epidemiologic evidence. Radiat. Res. 2005;136:247–257
  26. Paszat LF, Vallis KA, Benk VM, et al. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother. Oncol. 2007;82:294–300
  27. Pedersen AN, Korreman S, Nyström H, et al. Breathing adapted radiotherapy of breast cancer: Reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother. Oncol. 2004;72:53–60
  28. Hurkmans CW, Cho BC, Damen E, et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother. Oncol. 2002;62:163–171
  29. Taylor CW, Povall JM, McGale P, et al. Cardiac doses from tangential breast cancer radiotherapy in the year 2006. Int. J. Radiat. Oncol. Biol. Phys. 2008;72:501–507

PII: S0958-3947(09)00049-1

doi: 10.1016/j.meddos.2009.05.002

Medical Dosimetry
Volume 35, Issue 3 , Pages 163-168 , Autumn 2010